The Programmable Drug Delivery Service ecosystem spans three functional layers. Upstream participants—raw material suppliers and technology providers—deliver biocompatible polymers, micro‑chip platforms, and sensor components that enable programmable dosing. Midstream actors—OEM manufacturers and system integrators—transform these inputs into clinically validated delivery devices through assembly and software‑hardware integration. Downstream, distributors, service providers, and regulators ensure that finished systems reach hospitals or specialty pharmacies, remain operational, and comply with safety and data‑privacy standards. Value is created by coupling precise drug release capabilities with real‑time monitoring, and captured through device sales, service contracts, and data analytics.